Hans van Houte
Director of Finance/CFO presso NURIX THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Hans van Houte is currently the Chief Financial Officer at Nurix Therapeutics, Inc. He previously held positions as the Chief Accounting Officer, Treasurer & Controller at Vertex Pharmaceuticals, Inc., Vice President-Finance & Operations at Emergent Product Development Seattle, Chief Financial Officer at Igenica Biotherapeutics, Inc., and Managing Partner at Bionation LLC.
Mr. van Houte completed his undergraduate degree at Babson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0.14% | 21/03/2024 | 68 333 ( 0.14% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Hans van Houte
| Società | Posizione | Inizio |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2016 |
Precedenti posizioni note di Hans van Houte
| Società | Posizione | Fine |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | - |
| Bionation LLC | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - |
Formazione di Hans van Houte
| Babson College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
| Bionation LLC |
- Borsa valori
- Insiders
- Hans van Houte
